AGREEMENT FOR THE SUPPLY OF DARATUMUMAB FOR THE HOSPITAL DEL SALVADOR

This tender concerns an agreement for the supply of Daratumumab, a medication, specifically for the Hospital del Salvador. The objective is to establish a framework for the consistent and reliable provision of this pharmaceutical product to meet the hospital's patient care needs. While the description is brief, it implies a procurement process to secure a supply contract for Daratumumab. Key requirements would likely include adherence to strict quality standards for pharmaceutical products, timely delivery schedules, and potentially specific packaging and storage conditions to maintain product integrity. The tender is focused on the healthcare sector, specifically within the operations of a public hospital. The nature of the agreement suggests a medium to long-term commitment, ensuring continuous availability of the medication. Further details regarding the quantity, duration of the agreement, specific technical specifications for the Daratumumab, and the bidding process are expected to be outlined in the full tender documentation. This initiative by the Hospital del Salvador aims to guarantee access to essential treatments for patients requiring Daratumumab, underscoring the hospital's commitment to providing high-quality medical care.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors, with a focus on Hospitals, Pharmaceuticals, Manufacturing and General Supplies. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.